Privigen: Series Of Adverse Reactions
Privigen Recall Summary Privigen, an intravenous immunoglobulin product, has been recalled across Canada due to reports of adverse reactions in patients who received it. This is a Class I recall, meaning the product poses a serious risk to health. The recall affects Privigen distributed throughout Canada.
- Product
- Privigen
- Reason
- Adverse reaction
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2022-12-01
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/fb6737e0-3ace-46e9-b12f-92149fb2ebd0